Q2 2024 Holdings
Filed 2024-08-13 | 44 holdings | $340.3M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2024-08-13) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $29.0M | 1,412,176 | 8.5% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $28.7M | 2,712,741 | 8.4% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $26.7M | 1,011,879 | 7.9% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $24.7M | 551,095 | 7.3% |
| Merus N V | COM | N5749R100 | $17.1M | 288,668 | 5.0% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $15.5M | 280,709 | 4.6% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $14.8M | 1,495,047 | 4.4% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $11.5M | 339,351 | 3.4% |
| Applied Therapeutics Inc(APLT) | COM | 03828A101 | $10.3M | 2,211,320 | 3.0% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $10.2M | 81,508 | 3.0% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $9.5M | 245,933 | 2.8% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $9.3M | 2,662,732 | 2.7% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $9.0M | 965,392 | 2.6% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $8.8M | 1,178,105 | 2.6% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $8.7M | 736,765 | 2.6% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $8.1M | 233,255 | 2.4% |
| Vistagen Therapeutics Inc(VTGN) | COM | 92840H400 | $5.8M | 1,848,582 | 1.7% |
| Immatics N.v(IMTX) | SHS | N44445109 | $5.8M | 502,207 | 1.7% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $5.8M | 251,010 | 1.7% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $5.8M | 86,980 | 1.7% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $5.3M | 144,467 | 1.6% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $5.1M | 704,349 | 1.5% |
| Tscan Therapeutics Inc(TCRX) | COM | 89854M101 | $4.9M | 845,069 | 1.5% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $4.9M | 271,057 | 1.4% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $4.6M | 101,479 | 1.3% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $4.3M | 696,464 | 1.3% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $4.2M | 203,273 | 1.2% |
| Pyxis Oncology Inc(PYXS) | COMMON STOCK | 747324101 | $4.0M | 1,202,675 | 1.2% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $3.9M | 92,949 | 1.1% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $3.6M | 101,787 | 1.1% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $3.5M | 150,450 | 1.0% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $3.4M | 343,810 | 1.0% |
| Jasper Therapeutics Inc(JSPR) | COM NEW | 471871202 | $3.3M | 143,775 | 1.0% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $3.1M | 674,198 | 0.9% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $3.0M | 744,412 | 0.9% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $2.9M | 78,601 | 0.8% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $2.4M | 124,866 | 0.7% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $2.0M | 984,113 | 0.6% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $2.0M | 200,000 | 0.6% |
| Surrozen Inc(SRZN) | COM NEW | 86889P208 | $1.6M | 143,510 | 0.5% |
| Perceptive Cap Solutions COR | CL A ORD SHS | G70077105 | $1.5M | 150,000 | 0.4% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $1.2M | 29,259 | 0.4% |
| Arcutis Biotherapeutics Inc(ARQT)CallA | COM | 03969K108 | $350.0K | 500,000 | 0.1% |